J&J: stake in Kenvue to be sold off
Under the terms of the transaction, Johnson & Johnson will exchange 182.3 million shares of Kenvue common stock, worth some $3.75 billion, for debt securities that had been underwritten with Goldman Sachs and J. P. Morgan.P. Morgan.
Following the transaction, J&J will no longer hold any Kenvue shares.
Since the IPO of its former subsidiary last August, Johnson & Johnson still controlled 9.5% of outstanding common shares.
Kenvue owns the Band Aid, Johnson's, Listerine, Neutrogena and Tylenol brands, among others.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction